Delta Diagnostics
Ronald Vos serves as the Managing Director at RoVo Business Development since April 2019, focusing on short and mid-term projects in the LSR and Mol DX markets across the EMEA region. With extensive experience in the industry, having held leadership roles at CC Diagnostics as Chief Executive Officer since September 2021, KDx Diagnostics Inc. as EMEA Business Development Manager since August 2019, and SensID GmbH as Business Development Manager since May 2019, Ronald has developed a deep understanding of diverse markets, technologies, and sales strategies. Previous positions include Business Development roles at Delta Diagnostics, FOx Biosystems, SeraCare Life Sciences, MyCartis, and distribution management at Luminex BV and Thermo Fisher Scientific. Ronald Vos's educational background includes attendance at Amersfoortse Laboratorium School from 1982 to 1987.
This person is not in any teams
This person is not in any offices
Delta Diagnostics
Delta Diagnostics was founded in 2018 as a spin-off from TNO – The Netherlands Organisation for Applied Scientific Research. It commercializes the patented biosensor technology that has been developed at the Optics department of TNO.They believe that the availability of their rapid, sensitive and low-cost biosensors and instruments will lead tonew point-of-care diagnostic tests that will rely on the accurate concentration measurement of a panel of biomarkers within minutes.Since its founding, the company has grown steadily towards the highly-experienced and well-balanced team this is currently involved. During this time, it has worked hard to perfect its biosensing technology and prepare for the launch of its first product.Delta Diagnostics primarily focusses on the realization of its diagnostic test development platform and will partner with test developers to co-develop specific diagnostic tests.